Medical Research & Technology

San Francisco – September 07, 2026 -- Mito Health has run more than one million lab tests and expanded its direct-to-consumer diagnostics marketplace into seven categories of preventive testing, letting customers order bloodwork, imaging, and genetic screening without insurance, a doctor's referral, or a surprise bill.

The company built its first two years around 100-plus-biomarker longevity panels sold directly to consumers. Its catalog now covers fertility planning, strength and body composition testing, chronic disease baseline markers, nutrient and heavy-metal screening, inherited disease risk, and tuberculosis testing required for school enrollment.

Hudson, Florida – September 07, 2026 -- The Bonati Spine Institute has published a list of questions it says chronic back and neck pain patients should ask any surgeon proposing spinal surgery, timed to September's Pain Awareness Month.

"Most of the people who come to us have been in pain for years, and most of them have been treated for years," said Dr. Alfred Bonati, founder and chief orthopedic surgeon of the institute. "Many of them have never gotten a straight answer to one basic question: what specifically is generating this pain, and how do you know?"

Columbia, Md. – September 07, 2026 -- A new national survey from MedStar Health finds that 30% of men age 55 and older have never had a prostate exam, and nearly four in ten have skipped the prostate-specific antigen (PSA) blood test, despite prostate cancer being one of the most common cancers in men.

PSA screening is recommended at least every two to four years for average-risk men ages 55 through 69. About one in eight men will be diagnosed with prostate cancer during their lifetime.

Doctors say vague early symptoms lead men to delay testing

"Prostate cancer is common, and it may not cause clear symptoms early on," said Jonathan J. Hwang, MD, chair of Urology at MedStar Washington Hospital Center. "These findings show that many men may be putting off screening or may not know what warning signs to watch for."

Washington – September 07, 2026 -- A new analysis published in Blood Advances finds that treatment advances for leukemia, lymphoma, myeloma and other blood cancers have saved an estimated 25.8 million life-years in the United States since 1949. The study, led by Blood Cancer United, introduces a first-of-its-kind "life-years saved" methodology built on data from the National Cancer Institute's SEER Program, tracking cancer incidence, mortality and U.S. life expectancy from the era of the first chemotherapies through 2024.

Blood cancers now account for nearly 10% of all U.S. cancer diagnoses, with more than 192,000 new cases expected this year. Unlike many solid tumors, where screening and prevention drive survival gains, progress against blood cancers depends almost entirely on new therapies and access to them.

Little Rock – September 04, 2026 -- Kidney patients, family caregivers, and living organ donors can attend a four-day national meeting on kidney disease treatment and transplants at no cost starting September 10.

The American Association of Kidney Patients (AAKP) is hosting its 51st annual National Patient Meeting from September 10-13 in Little Rock, Arkansas. Admission and meals are free, with pre-registration available online or by calling (800) 749-2257.

The event opens with a policy forum at the Clinton Presidential Center

The gathering begins Thursday, September 10, with AAKP's Public Policy Forum at the William J. Clinton Presidential Center, running 1:00 p.m. to 4:00 p.m. Central Time. Doors open at noon with complimentary lunch, and the session covers kidney research innovation alongside federal regulatory and reimbursement decisions affecting patients.

PHILADELPHIA -- September 01, 2026 -- David Lozano, a Spanish rider with type 1 diabetes, won the King of the Mountains classification at the Philadelphia Cycling Classic on Saturday, claiming the climber's jersey as America's most prestigious one-day race returned after a decade away. Lozano, who races for Team Novo Nordisk, the world's first all-diabetes professional cycling team, led the day's decisive breakaway over the Manayunk Wall and Lemon Hill. Teammate Filippo Ridolfo finished 12th, the team's top overall result on the day.

SHERIDAN, WYOMING -- August 28, 2026 -- Virginia Cancer Specialists announced Aug. 28 that Kai-Li Liang, MD, has joined the Fairfax, Virginia practice as a medical oncologist and clinical investigator. The hire adds capacity to the largest community-based oncology clinical trials portfolio in the Mid-Atlantic region. Dr. Liang trained at Johns Hopkins University School of Medicine and Stony Brook University School of Medicine before arriving at the 10-location practice, which Castle Connolly has ranked the No. 1 physician practice in Virginia in cancer care and across all medical specialties for three straight years, from 2024 through 2026.